Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 4/20 | 0.73 |
| ▸ | NOS2 | P35228 | 8/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.56 |
| ▸ | USP7 | Q93009 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | STAT3 | P40763 | 1/20 | 0.56 |
| ▸ | CCR6 | P51684 | 1/20 | 0.49 |
| ▸ | RORC | P51449 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22428591 | 1.00 | MBOAT4 (0.73) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL23544236 | 1.00 | MBOAT4 (0.73) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL20750767 | 1.00 | MBOAT4 (0.73) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL21022618 | 1.00 | MBOAT4 (0.73) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL21022891 | 0.93 | MBOAT4 (0.63) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL21022355 | 0.92 | MBOAT4 (0.61) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL22428639 | 0.91 | MBOAT4 (0.60) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL25703400 | 0.91 | MBOAT4 (0.60) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL21022533 | 0.91 | MBOAT4 (0.74) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 | |
| SCHEMBL24917451 | 0.88 | NOS2 (0.70) | MBOAT4NOS2KEAP1CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2701698-B1 | DISORDERS IMPLICATING PUFA OXIDATION | RETROTOPE INC (US) | 2020-12-23 | — | — | EP | disclosed |
| EP-3730135-A1 | IMPAIRED ENERGY PROCESSING DISORDERS AND MITOCHONDRIAL DEFICIENCY | Retrotope, Inc. (US) | 2020-10-28 | — | — | EP | disclosed |
| EP-3689342-A1 | OXIDATIVE RETINAL DISEASES | Retrotope, Inc. (US) | 2020-08-05 | — | — | EP | disclosed |